Biotech entity
Every one of those 2 sits in a single category, pharma. Astellas Pharma is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. They are better corroborated than the beat average, carrying 4.5 original sources each against 3.2 for the same window.
Last mentioned: Mar 6, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, pharma. Astellas Pharma is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. They are better corroborated than the beat average, carrying 4.5 original sources each against 3.2 for the same window. Their average consequence score of 5 runs below the beat's 5.9 for that window. We currently track 2 Biotech stories that mention Iota Biosciences, published between March 5, 2026 and March 6, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 31 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Iota Biosciences. Shared-story counts are live from our verified record — not editorial picks.
Bioelectronic Medicine Forum
The forum convenes in NYC to discuss the future of neural interfaces.
Keynote Announcement
Jose Carmena announced as keynote for the 2026 Bioelectronic Medicine Forum in NYC.
Astellas Acquisition
Astellas Pharma acquires Iota Biosciences to bolster its 'Rx+' innovation strategy.
Iota Biosciences Founded
Jose Carmena and Michel Maharbiz spin out 'neural dust' technology from UC Berkeley.
The founder of Iota Biosciences will headline the 2026 Bioelectronic Medicine Forum in New York, marking a pivotal moment for the neurotechnology sector. The event will feature a global cohort of innovators, including European firms Coherence Neuro and Graphenicalab, alongside U.S. startup Spiro Medical.
Jose Carmena, co-founder of Iota Biosciences, has been named the keynote speaker for the 2026 Bioelectronic Medicine Forum in New York City. The event highlights the accelerating shift toward ultrasound-powered 'neural dust' and minimally invasive neuromodulation therapies.
Iota Biosciences is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
